New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia

NCT00670150 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped sponsor withdrew support

Conditions

Acute Promyelocytic Leukemia

Interventions

DRUG: NRX 195183 (retinoid analogue)
DRUG: Arsenic Trioxide

Sponsor

University of Southern California

Collaborators

[object Object]